Sort   by:  
 Page size 
UnknownPrognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials.
Not available
S-EPMC3477879 | biostudies-literature
UnknownAngiogenesis and lymphangiogenesis are downregulated in primary breast cancer.
Not available
S-EPMC2736814 | biostudies-literature
UnknownPredictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials.
Not available
S-EPMC4749471 | biostudies-literature
UnknownThe advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause.
Not available
S-EPMC4802157 | biostudies-literature
UnknownAssessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up.
Not available
S-EPMC3235950 | biostudies-literature
UnknownLetrozole therapy alone or in sequence with tamoxifen in women with breast cancer.
Not available
S-EPMC2921823 | biostudies-literature
Sort   by:  
 Page size